Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
1,092.00
0.00 (0.00%)
Jul 30, 2026, 5:24 PM IDT
[Name] Market Cap
TLV:REKA has a market cap or net worth of 126.47 million as of July 30, 2026. Its market cap has decreased by -5.94% in one year.
Market Cap
126.47M
Enterprise Value
251.51M
Revenue
304.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,092.00
ChartMarket Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 126.47M, an increase of 17.19%. That is a compound annual growth rate of 0.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 126.47M | 1.28% |
| Dec 31, 2025 | 124.88M | -17.43% |
| Dec 31, 2024 | 151.24M | -10.35% |
| Dec 31, 2023 | 168.71M | -3.96% |
| Dec 29, 2022 | 175.67M | -33.89% |
| Dec 30, 2021 | 265.73M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 110.65B |
| Kamada | 1.22B |
| InterCure | 159.23M |
| Seach Medical Group | 86.65M |
| Together Pharma | 38.37M |
| Nextage Therapeutics | 12.67M |
| PsyRX CNS Bio-Tech | 8.24M |
| Tikun Olam-Cannbit Pharmaceuticals | 2.64M |